This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
DraftKings (DKNG) Q2 Earnings Miss Estimates
by Zacks Equity Research
DraftKings (DKNG) delivered earnings and revenue surprises of -7.32% and +5.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DKNGPositive Net Change SLENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Encore Capital Group (ECPG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Encore Capital Group (ECPG) delivered earnings and revenue surprises of +72.92% and +15.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ECPGPositive Net Change GHINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Jack In The Box (JACK) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Jack In The Box (JACK) delivered earnings and revenue surprises of -12.07% and -2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JACKNegative Net Change QSRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Grand Canyon Education (LOPE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Grand Canyon Education (LOPE) delivered earnings and revenue surprises of +11.68% and +3.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LOPEPositive Net Change NRDYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Atmos Energy (ATO) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Atmos (ATO) delivered earnings and revenue surprises of -0.85% and -10.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ATOPositive Net Change CLNENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Barrett Business Services (BBSI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Barrett (BBSI) delivered earnings and revenue surprises of +7.69% and +2.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BBSINegative Net Change COHRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Traeger (COOK) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Traeger (COOK) delivered earnings and revenue surprises of -116.67% and -13.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
COOKPositive Net Change ADVNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CSG Systems (CSGS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CSG Systems (CSGS) delivered earnings and revenue surprises of +11.54% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CSGSPositive Net Change WYYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MKS (MKSI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
MKS (MKSI) delivered earnings and revenue surprises of +9.94% and +4.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MKSINegative Net Change UEICNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inotiv (NOTV) delivered earnings and revenue surprises of +20.00% and +4.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NOTVPositive Net Change COLLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sera Prognostics (SERA) delivered earnings and revenue surprises of +23.81% and -83.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SERAPositive Net Change SNDAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -20.00% and +0.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TNDMNegative Net Change PACBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Zillow Group (ZG) Q2 Earnings Miss Estimates
by Zacks Equity Research
Zillow (ZG) delivered earnings and revenue surprises of -9.09% and +1.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ZGPositive Net Change BETRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Green Thumb Industries Inc. (GTBIF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -125.00% and +4.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GTBIFNegative Net Change QIPTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Universal Technical Institute (UTI) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of +58.33% and +1.82%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UTIPositive Net Change ATGEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Mistras (MG) Beats Q2 Earnings Estimates
by Zacks Equity Research
Mistras (MG) delivered earnings and revenue surprises of +11.76% and -0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MGPositive Net Change OSSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PRCTNegative Net Change NPCEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sunrun (RUN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Sunrun (RUN) delivered earnings and revenue surprises of +694.44% and +2.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RUNNegative Net Change CSIQNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sarepta Therapeutics (SRPT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of +81.98% and +15.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SRPTNegative Net Change BHSTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Steris (STE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Steris (STE) delivered earnings and revenue surprises of +0.86% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STENegative Net Change SRTSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CDNAPositive Net Change ESTANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Corteva, Inc. (CTVA) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of +16.40% and +3.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CTVANegative Net Change ALCOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Immunome (IMNM) delivered earnings and revenue surprises of +3.85% and +62.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IMNMNegative Net Change DTILNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Keros Therapeutics (KROS) delivered earnings and revenue surprises of +33.33% and +135.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KROSPositive Net Change YMABNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Howard Hughes Holdings (HHH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Howard Hughes Holdings (HHH) delivered earnings and revenue surprises of -56.44% and -12.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HHHNegative Net Change TRUPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank